BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35091528)

  • 1. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients.
    Song Z; Bao L; Deng W; Liu J; Ren E; Lv Q; Liu M; Qi F; Chen T; Deng R; Li F; Liu Y; Wei Q; Gao H; Yu P; Han Y; Zhao W; Zheng J; Liang X; Yang F; Qin C
    Signal Transduct Target Ther; 2022 Jan; 7(1):29. PubMed ID: 35091528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection in farmed minks, associated zoonotic concerns, and importance of the One Health approach during the ongoing COVID-19 pandemic.
    Sharun K; Tiwari R; Natesan S; Dhama K
    Vet Q; 2021 Jan; 41(1):50-60. PubMed ID: 33349165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication, pathogenicity, and transmission of SARS-CoV-2 in minks.
    Shuai L; Zhong G; Yuan Q; Wen Z; Wang C; He X; Liu R; Wang J; Zhao Q; Liu Y; Huo N; Deng J; Bai J; Wu H; Guan Y; Shi J; Tian K; Xia N; Chen H; Bu Z
    Natl Sci Rev; 2021 Mar; 8(3):nwaa291. PubMed ID: 34676095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans.
    Konishi T
    PLoS One; 2021; 16(5):e0247626. PubMed ID: 34038423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
    Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
    FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreaks of SARS-CoV-2 in naturally infected mink farms: Impact, transmission dynamics, genetic patterns, and environmental contamination.
    Chaintoutis SC; Thomou Z; Mouchtaropoulou E; Tsiolas G; Chassalevris T; Stylianaki I; Lagou M; Michailidou S; Moutou E; Koenen JJH; Dijkshoorn JW; Paraskevis D; Poutahidis T; Siarkou VI; Sypsa V; Argiriou A; Fortomaris P; Dovas CI
    PLoS Pathog; 2021 Sep; 17(9):e1009883. PubMed ID: 34492088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology and localization of SARS-CoV-2 and its host cell entry receptor ACE2 in tissues from naturally infected US-farmed mink (
    Ritter JM; Wilson TM; Gary JM; Seixas JN; Martines RB; Bhatnagar J; Bollweg BC; Lee E; Estetter L; Silva-Flannery L; Bullock HA; Towner JS; Cossaboom CM; Wendling NM; Amman BR; Harvey RR; Taylor D; Rettler H; Barton Behravesh C; Zaki SR
    Vet Pathol; 2022 Jul; 59(4):681-695. PubMed ID: 35229669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
    Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
    Front Immunol; 2022; 13():811430. PubMed ID: 35250984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: SARS-CoV-2 infection in farmed minks - an overview of current knowledge on occurrence, disease and epidemiology.
    Pomorska-Mól M; Włodarek J; Gogulski M; Rybska M
    Animal; 2021 Jul; 15(7):100272. PubMed ID: 34126387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands.
    Lu L; Sikkema RS; Velkers FC; Nieuwenhuijse DF; Fischer EAJ; Meijer PA; Bouwmeester-Vincken N; Rietveld A; Wegdam-Blans MCA; Tolsma P; Koppelman M; Smit LAM; Hakze-van der Honing RW; van der Poel WHM; van der Spek AN; Spierenburg MAH; Molenaar RJ; Rond J; Augustijn M; Woolhouse M; Stegeman JA; Lycett S; Oude Munnink BB; Koopmans MPG
    Nat Commun; 2021 Nov; 12(1):6802. PubMed ID: 34815406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Outbreak on a Spanish Mink Farm: Epidemiological, Molecular, and Pathological Studies.
    Badiola JJ; Otero A; Sevilla E; Marín B; García Martínez M; Betancor M; Sola D; Pérez Lázaro S; Lozada J; Velez C; Chiner-Oms Á; Comas I; Cancino-Muñoz I; Monleón E; Monzón M; Acín C; Bolea R; Moreno B
    Front Vet Sci; 2021; 8():805004. PubMed ID: 35127883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Pathological Findings in SARS-CoV-2 Disease Outbreaks in Farmed Mink (
    Molenaar RJ; Vreman S; Hakze-van der Honing RW; Zwart R; de Rond J; Weesendorp E; Smit LAM; Koopmans M; Bouwstra R; Stegeman A; van der Poel WHM
    Vet Pathol; 2020 Sep; 57(5):653-657. PubMed ID: 32663073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An outbreak of SARS-CoV-2 with high mortality in mink (Neovison vison) on multiple Utah farms.
    Eckstrand CD; Baldwin TJ; Rood KA; Clayton MJ; Lott JK; Wolking RM; Bradway DS; Baszler T
    PLoS Pathog; 2021 Nov; 17(11):e1009952. PubMed ID: 34767598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
    Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
    J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
    Ansone L; Briviba M; Silamikelis I; Terentjeva A; Perkons I; Birzniece L; Rovite V; Rozentale B; Viksna L; Kolesova O; Klavins K; Klovins J
    Microbiol Spectr; 2021 Dec; 9(3):e0033821. PubMed ID: 34878333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
    Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I
    Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.
    Glebov OO
    FEBS J; 2020 Sep; 287(17):3664-3671. PubMed ID: 32428379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals.
    Gassen NC; Papies J; Bajaj T; Emanuel J; Dethloff F; Chua RL; Trimpert J; Heinemann N; Niemeyer C; Weege F; Hönzke K; Aschman T; Heinz DE; Weckmann K; Ebert T; Zellner A; Lennarz M; Wyler E; Schroeder S; Richter A; Niemeyer D; Hoffmann K; Meyer TF; Heppner FL; Corman VM; Landthaler M; Hocke AC; Morkel M; Osterrieder N; Conrad C; Eils R; Radbruch H; Giavalisco P; Drosten C; Müller MA
    Nat Commun; 2021 Jun; 12(1):3818. PubMed ID: 34155207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational and environmental exposure to SARS-CoV-2 in and around infected mink farms.
    de Rooij MMT; Hakze-Van der Honing RW; Hulst MM; Harders F; Engelsma M; van de Hoef W; Meliefste K; Nieuwenweg S; Oude Munnink BB; van Schothorst I; Sikkema RS; van der Spek AN; Spierenburg M; Spithoven J; Bouwstra R; Molenaar RJ; Koopmans M; Stegeman A; van der Poel WHM; Smit LAM
    Occup Environ Med; 2021 Dec; 78(12):893-899. PubMed ID: 34330815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.